Acandis

Acandis is a privately held medical device company focused on the neurovascular market, specifically stroke treatment. Its core innovation is the HEAL Technology, a proprietary anti-thrombogenic coating designed to improve the integration and safety of intracranial implants like stents and flow diverters. The company has a commercial portfolio of products for stroke care and is actively expanding its reach through distributor networks and clinical studies. Acandis positions itself as an engineering-driven firm aiming to advance stroke prevention and treatment through device miniaturization and biomimetic surface technologies.

HEAL Technology: A proprietary, non-eluting, biomimetic surface coating for intracranial devices. It combines a polymerized fibrin network with covalently bound heparin to create anti-thrombogenic and pro-endothelialization properties, promoting device integration and reducing complications.

Acandis competes in the neurovascular device market against global giants like Medtronic, Stryker, and Johnson & Johnson, as well as other specialized players. Its differentiation is based on its proprietary HEAL coating technology, aiming to offer superior biocompatibility and healing characteristics for intracranial stents and flow diverters.